| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiotherapy and Oncology, Queen Mary Hospital, Pokfulam, Hong Kong
Correspondence: * Author for correspondence.
The records of 759 Stage I to IV nasopharyngeal carcinoma patients seen between January 1976 and December 1983 were reviewed. There were 72 (9.5%), 162 (21.3%), 317 (41.8%) and 208 (27.4%) patients with Stage I, II, III and IV disease, respectively. Ho's stage classification was found to give a reliable prognosis. The actuarial survival at 5 and 10 years for Stage I, II, III and IV disease was 80.8%, 71.5%, 40.7%, 17.7% and 33.4%, 48.4%, 30.0%, 9.5%, respectively. The significant factors affecting survival were found using Cox multivariate analysis, N and T stages, the size and degree of fixation of neck nodes, sex, age, the presence of cranial nerve palsy and ear symptoms at presentation. Bilateral neck node involvement, histology subtypes of tumour, headache and nasal symptoms at presentation, the difference in radiation dose to the primary tumour and the neck, the initial haemoglobin and white blood count were not significant factors in the present study. The N stage was found to be prognostically significant even among patient groups stratified for the size and degree of fixation of the neck nodes involved. Women bad a better survival rate than men, and the survival of patients less than 40 years old was better than those who were older at 5 years, although by 10 years the survival for the two groups was comparable.
Received for publication April 1, 1989.
Revision received August 1, 1989.
This article has been cited by other articles:
![]() |
C Y CHEN, F HAN, C ZHAO, L X LU, Y SUN, X F LIU, and T X LU Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone Br. J. Radiol., June 1, 2009; 82(978): 452 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, T. Kodaira, H. Tachibana, N. Tomita, T. Tomoda, R. Nakahara, H. Inokuchi, N. Mizoguchi, A. Takada, and N. Fuwa Chemoradiotherapy for Locally Recurrent Nasopharyngeal Carcinoma: Treatment Outcome and Prognostic Factors Jpn. J. Clin. Oncol., December 1, 2008; 38(12): 803 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Tse, N.-M. Tsang, K.-D. Chen, H.-P. Li, Y. Liang, C. Hsueh, K.-P. Chang, J.-S. Yu, S.-P. Hao, L.-L. Hsieh, et al. MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment Clin. Cancer Res., November 1, 2007; 13(21): 6320 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Sun, C. I. Li, E.-Y. Huang, and T. L. Vaughan Survival Differences by Race in Nasopharyngeal Carcinoma Am. J. Epidemiol., February 1, 2007; 165(3): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Yeh, Y. Tang, C.-C. Lui, and E.-Y. Huang Treatment Outcomes of Patients with AJCC Stage IVC Nasopharyngeal Carcinoma: Benefits of Primary Radiotherapy Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 132 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Choi and W. S. Lee Curative Surgery for Recurrent Nasopharyngeal Carcinoma via the Infratemporal Fossa Approach Arch Otolaryngol Head Neck Surg, March 1, 2005; 131(3): 213 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Z. Ibrahim, M. S. Moir, and W. W. Fee Nasopharyngectomy After Failure of 2 Courses of Radiation Therapy Arch Otolaryngol Head Neck Surg, October 1, 2002; 128(10): 1196 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-L. Hong, L.-L. Ting, J.-Y. Ko, M.-M. Hsu, T.-S. Sheen, P.-J. Lou, C.-C. Wang, N.-N. Chung, and L. T. Lui Induction Chemotherapy With Mitomycin, Epirubicin, Cisplatin, Fluorouracil, and Leucovorin Followed by Radiotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma J. Clin. Oncol., December 1, 2001; 19(23): 4305 - 4313. [Abstract] [Full Text] |
||||
![]() |
W. I. Wei Nasopharyngeal Cancer: Current Status of Management: A New York Head and Neck Society Lecture Arch Otolaryngol Head Neck Surg, July 1, 2001; 127(7): 766 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Cheng, S. Y. C. Tsai, K. L. Yen, J. J.-M. Jian, N.-M. Chu, K.-Y. Chan, T.-D. Tan, J. C. Cheng, C.-Y. Hsieh, and A. T. Huang Concomitant Radiotherapy and Chemotherapy for Early-Stage Nasopharyngeal Carcinoma J. Clin. Oncol., May 10, 2000; 18(10): 2040 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Kau, C. Alexiou, C. Laubenbacher, M. Werner, M. Schwaiger, and W. Arnold Lymph Node Detection of Head and Neck Squamous Cell Carcinomas by Positron Emission Tomography With Fluorodeoxyglucose F 18 in a Routine Clinical Setting Arch Otolaryngol Head Neck Surg, December 1, 1999; 125(12): 1322 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Yen, L.-P. Hsu, T.-S. Sheen, Y.-L. Chang, and M.-M. Hsu Salvage Neck Dissection for Cervical Recurrence of Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, July 1, 1997; 123(7): 725 - 729. [Abstract] [PDF] |
||||
![]() |
M.-M. Hsu, J.-Y. Ko, T.-S. Sheen, and Y.-L. Chang Salvage Surgery for Recurrent Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, March 1, 1997; 123(3): 305 - 309. [Abstract] [PDF] |
||||
![]() |
J. S. T. Sham, W. I. Wei, S. K. Lau, C. C. Yau, and D. Choy Serous Otitis Media: An Opportunity for Early Recognition of Nasopharyngeal Carcinoma Arch Otolaryngol Head Neck Surg, August 1, 1992; 118(8): 794 - 797. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |